CPSA Shanghai 2013

Reviving Pharmaceutical R&D with Translational Science, Regulatory Efficiency, and Innovative Models

April 24 - 27, 2013
Renaissance Shanghai Pudong Hotel
Shanghai, China

Pharmaceutical Science Workshop

Download CPSA Shanghai 2013 Registration Form

Analytical & Quality Consideration in Pharmaceutical Science

Wednesday, April 24, 2013
9:00 AM - 4:30 pm

Organized by:
CPSA Shanghai and Pharma-Valley Analytical Discussion Group (PVADG)

Hosted by:
Pharmaceutical Analysis & Solid-State Chemistry Research Center
Shanghai Institute of Materia Medica
Chenggu Hall, 555 Zu-Chong-Zhi Road
Pudong New District, Shanghai

Workshop Co-chairs:
Yong-Guo "Fred" Li, Hua Medicine, Ltd.
Todd Gillespie, Eli Lilly & Co.

Download workshop program

Morning Session (9:00 AM - 12:00 PM)
Chairs: Yong-Guo "Fred" Li, Hua Medicine, Ltd.; Xuefeng Mei, Shanghai Institute of Materia Medica

Welcome and Introduction
Todd Gillespie, Eli Lilly & Co.
Yong-Guo "Fred" Li, Hua Medicine, Ltd.

Solid State Characterization and Pharmaceutical Profiling for Pharmaceutical Development
Xuefeng Mei, Shanghai Institute of Materia Medica

Stability Consideration in Drug Discovery & Development
Ms. Lan Lin, WuxiApptec

Afternoon Session (1:00 PM - 4:30 PM)
Chairs: Marc Cao, Eli Lilly R&D China; Baiming Xao, Jiangsu Simcere Pharmaceutical Group, Ltd.

Challenges for Generic Drug Impurity Studies
Baiming Xiao, Jiangsu Simcere Pharmaceutical Group, Ltd.

Integrating Analytical Science & Technologies to Support Drug Discovery & Development
Penny Ding, Roche R&D Center

Panel Discussion: Key Points of Analytics in Drug Development
Discussion Leader: Yong-Guo "Fred" Li, Hua Medicine, Ltd.

Panelists:
Todd Gillespie, Eli Lilly & Co.
Bo Zhang, GlaxoSmithKline (China)
Marc Cao, Eli Lilly R&D (China)
Baiming Xiao, Jiangsu Simcere Pharmaceutical Group, Ltd.

CPSA Shanghai - Where Technology and Solutions Meet. Where East Meets West.